If results are favorable then this will be trading between $2-4/share but thats the gamble. It is taking an unusual amount of time for them to post results and file with the FDA?
The biggest thing they need to do is get back on OTC trading and off the skull and crossbones status. They can be making money selling stock to fund this R&D.